OSANG Healthcare has been a leader in the Korean IVD (In-Vitro Diagnosis) industry since its founding in 1996,
ever expanding a wide array of medical devices for biochemical, immunoassay, molecular diagnostics, and digital healthcare.
OSANG Healthcare Co., was the first South Korean SARS-CoV-2 test kit producer to receive authorization from the U.S. Food & Drug Administration in April 2020.
The company has supplied countries all over the world and has already sold 760,000 tests to US customers, including the Federal Emergency Management Agency,
Agency (FEMA). Giving the first priority to our customers and partners, we will further develop powerful synergies with other affiliates in the group.